medigraphic.com
ISSN 1870-199X (Print)
Órgano oficial de la Facultad de Odontología, UNAM

2009, Number 1

<< Back Next >>

Rev Odont Mex 2009; 13 (1)

Hemimaxillectomy in rhinocerebral mucormycosis. Case report

Vargas AOJ, Miranda VJE, Baldomero HJ

Language: Spanish
References: 25
Page: 47-52
PDF size: 336.49 Kb.


ABSTRACT

The rhinocerebral mucormycosis is a fungical, lethal and uncommon disease usually observed in diabetic or immunodeficient patients. Usually the treatment is done by controlling the underlying disease, as well as a radical debridement, usually a partial or total maxillectomy is done and in some cases is also included ethmoidectomy and orbital exenteration. As well as therapy with Amphothericin B is initiated. This case report describes a 69-year-old male patient that suffered a rhinocerebral mucormycosis of an atypical evolution; due to the initial phase which did not present the typical metabolic chaos and the abnormal timing of appearance of the signs. As soon as the diagnosis was confirmed, a treatment with amphotericin B was established and an hemimaxillectomy was carried out with debridement by means of Weber-Ferguson approach.


REFERENCES

  1. Marx RE, Stern D. Oral and maxillofacial pathology. A rationale for diagnosis and treatment. USA. Quintessence publishing Co; 2003.

  2. Willard RJ. Micología médica. 3a edición. México. ed Interamericana- Mc Graw-Hill; 1990.

  3. Gregory JE, Golden A, Haymaker W. Mucormycosis of the central nervous system; a report of three cases. Bull Johns Hopkins Hosp 1943; 73: 405-419.

  4. Harris J. Mucormycosis: Report of a case. J Pediatr 1955; 16: 857-867.

  5. Karsner HT, Saphir O. Influence of high partial pressures of oxygen on the growth of certain molds. J Infect Dis 1926; 39: 231-236.

  6. Price JC, Stevens DL. Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope 1980; 90: 737-747.

  7. Ferguson BJ, Mitchell TG, Moon R. Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis 1988; 10: 551.

  8. Sztern CD, Begue P, Greco M, Cechinni E. Mucormicosis rinosinusal en paciente inmunocomprometido (serial online). 2003 Sept [cited may 2000]. Available from: URL: http://www.A:Mucormicosis rinosinusal.htm.

  9. Bonifaz A. Micología médica básica. 2ª edición. México. Ed Méndez editores; 2002.

  10. Tristano A, Chollet MaE. Mucormicosis. Reporte de tres casos. Invest Clin Maracaibo 2002: 43(3).

  11. Ferguson BJ. Fungal rhinosinusitis: a spectrum of disease. Otolaryn Clin North Am 2000: 3(2).

  12. Tsoutsos D, Tsati E. Extensive Burn injury complicated by mucormicosis: a case report. Ann Burn and Fire Disast 2001; XIV: 3.

  13. Jone K, James KF, Harold EC. A fatal outcome from rhinocerebral Mucormycosis after extractions: A case report. J Oral Maxillofac Surg 2001; 59: 693-697.

  14. Topazian GR. Goldberg HM. Oral and maxillofacial infections. USA Saunders Co; 1994.

  15. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Sun Ophthalmol 1994; 39: 3-22.

  16. Bodenstein NP. Clinical signs of orbital ischemia in rhino-orbitocerebral mucormycosis. Laryngoscope 1993; 103: 1357-61.

  17. Maertens. Bone marrow transplant.1999; 24(3): 307-12.

  18. Boelaert: Clin Nephrol 1988; 29(5): 261-6.

  19. Boelaert. Am J Kidney Dis 1991; 18: 660-7.

  20. Waizel-haiat S, Cohn-Zurita F, Vargas A, Ramírez AR, Vivar AE. Mucormicosis rinocerebral invasora crónica. Cir Ciruj 2003; 71: 145-149.

  21. Hopkins D. Clin Infect Dis 1994; 19(6): 1133-7.

  22. Chun S, Stevens DA. Cecil textbook of medicine. 21st ed. USA. Saunders Company; 2000: 1884-1886.

  23. Strasser R. Arch Intern Med 1996; 156(3): 337-9.

  24. Hardman JG, Limbird LE, editors. Las bases farmacológicas de la terapéutica. Octava ed. México: McGraw-Hill-Interamericana., 1996.

  25. Nussbaum ES, Hall WA. Rhinocerebral mucormycosis: Changing pattern of disease. Surg Neurol 1994; 41: 152-155.




2020     |     www.medigraphic.com